CM
PBH icon

CS McKee’s Prestige Consumer Healthcare PBH Stock Holding History

CS McKee’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1.31M Buy
32,440
+2,390
+8% +$89.2K 0.12% 77
2019
Q3 		$1.04M Hold
30,050
– – 0.09% 78
2019
Q2 		$952K Sell
30,050
-1,900
-6% -$56.5K 0.08% 84
2019
Q1 		$956K Sell
31,950
-400
-1% -$11.5K 0.08% 87
2018
Q4 		$999K Hold
32,350
– – 0.1% 83
2018
Q3 		$1.23M Hold
32,350
– – 0.1% 90
2018
Q2 		$1.24M Sell
32,350
-3,000
-8% -$101K 0.11% 88
2018
Q1 		$1.19M Sell
35,350
-1,300
-4% -$49.9K 0.09% 88
2017
Q4 		$1.63M Sell
36,650
-100
-0.3% -$4.55K 0.12% 75
2017
Q3 		$1.84M Buy
36,750
+1,600
+5% +$81.7K 0.14% 68
2017
Q2 		$1.86M Buy
35,150
+100
+0.3% +$5.36K 0.15% 68
2017
Q1 		$1.95M Sell
35,050
-300
-0.8% -$16.5K 0.16% 68
2016
Q4 		$1.84M Sell
35,350
-2,850
-7% -$138K 0.14% 68
2016
Q3 		$1.84M Sell
38,200
-4,950
-11% -$250K 0.12% 68
2016
Q2 		$2.39M Sell
43,150
-52,555
-55% -$2.89M 0.1% 67
2016
Q1 		$5.11M Sell
95,705
-115,394
-55% -$5.68M 0.19% 65
2015
Q4 		$10.9M Sell
211,099
-12,575
-6% -$625K 0.35% 64
2015
Q3 		$10.1M Sell
223,674
-43,750
-16% -$2.07M 0.33% 66
2015
Q2 		$12.4M Sell
267,424
-23,835
-8% -$1.04M 0.34% 65
2015
Q1 		$12.5M Sell
291,259
-47,600
-14% -$1.81M 0.33% 64
2014
Q4 		$11.8M Sell
338,859
-171,721
-34% -$5.7M 0.28% 67
2014
Q3 		$16.5M Sell
510,580
-88,350
-15% -$2.96M 0.38% 65
2014
Q2 		$20.3M Sell
598,930
-84,520
-12% -$2.71M 0.43% 62
2014
Q1 		$18.6M Sell
683,450
-90,560
-12% -$2.69M 0.4% 70
2013
Q4 		$27.7M Sell
774,010
-522,530
-40% -$17.4M 0.54% 55
2013
Q3 		$39.1M Sell
1,296,540
-80,070
-6% -$2.62M 0.66% 50
2013
Q2 		$40.1M Buy
+1,376,610
New +$38.8M 0.68% 51

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

CS McKee's PBH Position: Q4 2019 in Review

CS McKee increased its Prestige Consumer Healthcare (PBH) stake by 8% in Q4 2019, buying an estimated $89.2K and bringing the position to 32,440 shares worth $1.31M. The position accounts for 0.12% of the portfolio, ranked #77.

CS McKee first reported a position in PBH in Q2 2013 and has held it in 27 quarters since. The position peaked at $40.1M in Q2 2013. 234 funds tracked by Wall St. Rank hold PBH as of Q4 2019.

  • CS McKee held 32,440 shares of Prestige Consumer Healthcare worth $1.31M as of Q4 2019.
  • CS McKee bought 2,390 Prestige Consumer Healthcare shares in Q4 2019, an estimated $89.2K.
  • Prestige Consumer Healthcare made up 0.12% of CS McKee's portfolio in Q4 2019, its #77 holding.
  • CS McKee first reported a position in Prestige Consumer Healthcare in Q2 2013 and has held it in 27 quarters since.
  • CS McKee's Prestige Consumer Healthcare position peaked at $40.1M in Q2 2013.
  • 234 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2019.

Based on CS McKee's 13F filing for Q4 2019, filed 14 Feb 2020.